Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
PaperCitations, authors & open-access status
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 440 citations, 2013 year and bronze oa status.
440
Citations
2013
Year
bronze
OA Status